JP2008514577A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514577A5 JP2008514577A5 JP2007532963A JP2007532963A JP2008514577A5 JP 2008514577 A5 JP2008514577 A5 JP 2008514577A5 JP 2007532963 A JP2007532963 A JP 2007532963A JP 2007532963 A JP2007532963 A JP 2007532963A JP 2008514577 A5 JP2008514577 A5 JP 2008514577A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- imatinib
- acceptable salt
- warm
- man
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 11
- 239000005517 L01XE01 - Imatinib Substances 0.000 claims 10
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 claims 10
- 229960002411 imatinib Drugs 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 241001465754 Metazoa Species 0.000 claims 9
- 230000005865 ionizing radiation Effects 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 230000001772 anti-angiogenic effect Effects 0.000 claims 3
- 230000001603 reducing effect Effects 0.000 claims 3
- 230000008728 vascular permeability Effects 0.000 claims 3
- 206010041067 Small cell lung cancer Diseases 0.000 claims 2
- 230000001093 anti-cancer Effects 0.000 claims 2
- 230000000259 anti-tumor effect Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 2
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0421438A GB0421438D0 (en) | 2004-09-27 | 2004-09-27 | Combination therapy |
| GB0506726A GB0506726D0 (en) | 2005-04-01 | 2005-04-01 | Combination therapy |
| PCT/GB2005/003673 WO2006035204A2 (en) | 2004-09-27 | 2005-09-23 | Combination comprising zd6474 and an imatinib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008514577A JP2008514577A (ja) | 2008-05-08 |
| JP2008514577A5 true JP2008514577A5 (OSRAM) | 2008-08-28 |
Family
ID=35924044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532963A Pending JP2008514577A (ja) | 2004-09-27 | 2005-09-23 | Ｚｄ６４７４及びイマチニブを含んでなる組合せ |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20080119479A1 (OSRAM) |
| EP (1) | EP1804802A2 (OSRAM) |
| JP (1) | JP2008514577A (OSRAM) |
| KR (1) | KR20070072543A (OSRAM) |
| AU (1) | AU2005288737B2 (OSRAM) |
| BR (1) | BRPI0516052A (OSRAM) |
| CA (1) | CA2578956A1 (OSRAM) |
| IL (1) | IL181609A0 (OSRAM) |
| MX (1) | MX2007003505A (OSRAM) |
| NO (1) | NO20071428L (OSRAM) |
| WO (1) | WO2006035204A2 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
| GB0126879D0 (en) * | 2001-11-08 | 2002-01-02 | Astrazeneca Ab | Combination therapy |
| GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
| GB0223380D0 (en) * | 2002-10-09 | 2002-11-13 | Astrazeneca Ab | Combination therapy |
| ATE506062T1 (de) * | 2003-02-13 | 2011-05-15 | Astrazeneca Ab | Kombinationstherapie von zd6474 mit 5-fu oder/und cpt-11 |
| GB0310401D0 (en) * | 2003-05-07 | 2003-06-11 | Astrazeneca Ab | Therapeutic agent |
| WO2005004870A1 (en) * | 2003-07-10 | 2005-01-20 | Astrazeneca Ab | Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| GB0424339D0 (en) * | 2004-11-03 | 2004-12-08 | Astrazeneca Ab | Combination therapy |
| EP1971338B8 (en) * | 2005-12-22 | 2011-09-21 | AstraZeneca AB | Combination of zd6474 and pemetrexed |
| WO2008037996A1 (en) * | 2006-09-29 | 2008-04-03 | Astrazeneca Ab | Combination of zd6474 and bevacizumab for cancer therapy |
| EP3352107B1 (en) | 2008-03-03 | 2025-10-22 | NIKE Innovate C.V. | Interactive athletic equipment system |
| US8231506B2 (en) | 2008-12-05 | 2012-07-31 | Nike, Inc. | Athletic performance monitoring systems and methods in a team sports environment |
| US8628453B2 (en) | 2008-12-05 | 2014-01-14 | Nike, Inc. | Athletic performance monitoring systems and methods in a team sports environment |
| US8172722B2 (en) | 2008-12-05 | 2012-05-08 | Nike, Inc. | Athletic performance monitoring systems and methods in a team sports environment |
| KR101560955B1 (ko) | 2010-11-10 | 2015-10-15 | 나이키 이노베이트 씨.브이. | 시간 기반 체육 활동 측정 및 표시를 위한 시스템 및 방법 |
| EP2676214A1 (en) | 2011-02-17 | 2013-12-25 | Nike International Ltd. | Tracking of user performance metrics during a workout session |
| KR101386697B1 (ko) * | 2012-06-18 | 2014-04-18 | 아주대학교산학협력단 | 이매티닙 또는 이의 약학적으로 허용되는 염을 유효성분으로 포함하는 혈관 투과성 관련 질환의 치료 또는 예방용 조성물 |
| AU2014296032A1 (en) | 2013-07-31 | 2016-03-17 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
| KR101778004B1 (ko) | 2015-06-22 | 2017-09-15 | (주) 에빅스젠 | 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물 |
| US11957681B2 (en) | 2017-07-26 | 2024-04-16 | Shorla Pharma Limited | Liquid dosage forms of Imatinib |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL149034A0 (en) * | 1999-11-05 | 2002-11-10 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
| GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
| GB0126879D0 (en) * | 2001-11-08 | 2002-01-02 | Astrazeneca Ab | Combination therapy |
| JP2006501147A (ja) * | 2002-04-25 | 2006-01-12 | ユニバーシティー オブ コネティカット ヘルス センター | 非ワクチン治療法の治療効果を改善するための熱ショックタンパク質の使用 |
| GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
| EP1534287A1 (en) * | 2002-08-09 | 2005-06-01 | Astrazeneca AB | Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer |
| GB0223380D0 (en) * | 2002-10-09 | 2002-11-13 | Astrazeneca Ab | Combination therapy |
| ATE506062T1 (de) * | 2003-02-13 | 2011-05-15 | Astrazeneca Ab | Kombinationstherapie von zd6474 mit 5-fu oder/und cpt-11 |
| WO2005004870A1 (en) * | 2003-07-10 | 2005-01-20 | Astrazeneca Ab | Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| US20080015205A1 (en) * | 2004-09-27 | 2008-01-17 | Wedge Stephen R | Cancer Combination Therapy Comprising Azd2171 and Imatinib |
| GB0424339D0 (en) * | 2004-11-03 | 2004-12-08 | Astrazeneca Ab | Combination therapy |
| EP1971338B8 (en) * | 2005-12-22 | 2011-09-21 | AstraZeneca AB | Combination of zd6474 and pemetrexed |
-
2005
- 2005-09-23 EP EP05786268A patent/EP1804802A2/en not_active Withdrawn
- 2005-09-23 WO PCT/GB2005/003673 patent/WO2006035204A2/en not_active Ceased
- 2005-09-23 AU AU2005288737A patent/AU2005288737B2/en not_active Ceased
- 2005-09-23 MX MX2007003505A patent/MX2007003505A/es not_active Application Discontinuation
- 2005-09-23 US US11/663,913 patent/US20080119479A1/en not_active Abandoned
- 2005-09-23 JP JP2007532963A patent/JP2008514577A/ja active Pending
- 2005-09-23 CA CA002578956A patent/CA2578956A1/en not_active Abandoned
- 2005-09-23 BR BRPI0516052-9A patent/BRPI0516052A/pt not_active IP Right Cessation
- 2005-09-23 KR KR1020077009369A patent/KR20070072543A/ko not_active Withdrawn
-
2007
- 2007-02-27 IL IL181609A patent/IL181609A0/en unknown
- 2007-03-16 NO NO20071428A patent/NO20071428L/no not_active Application Discontinuation
-
2009
- 2009-06-05 US US12/479,131 patent/US20100069398A1/en not_active Abandoned